AI assistant
Sending…
BECTON DICKINSON & CO — Director's Dealing 2004
Nov 17, 2004
30003_dirs_2004-11-17_b104dcd8-33f9-4fec-b1ef-a84cb8704496.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2004-11-16
Reporting Person: FORLENZA VINCENT A (President - BD Biosciences)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2004-11-16 | Common Stock | M | 102538 | $24.8125 | Acquired | 142182 | Direct |
| 2004-11-16 | Common Stock | S | 102538 | $54.81 | Disposed | 39644 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2004-11-16 | Employee Stock Option (right to buy) | $24.8125 | M | 102538 | Disposed | 2007-01-27 | Common Stock (102538) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4704 | Indirect |
Footnotes
F1: Represents an interest in shares of common stock held under the Becton, Dickinson and Company Savings Incentive Plan (the "SIP"). Mr. Forlenza also has an interest in 541 shares of Series B Convertible Preferred Stock under the SIP, which are convertible into 3,462 shares of common stock. The information presented for the SIP is as of October 31, 2004.
F2: The option became 50% exercisable on January 27, 1999 and fully exercisable on January 27, 2000.
More from BECTON DICKINSON & CO
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 13
Capital/Financing Update
2026
May 12
Capital/Financing Update
2026
May 11
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 7
Share Issue/Capital Change
2026
May 7
Interim / Quarterly Report
2026
May 7